Yunzi Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunzi Luo has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Huayi Liu
Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
18 shared publications Chaoqun Huang
Frontiers Science Center for Synthetic Biology (Ministry of Education), School of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China; State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China; School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
8 shared publicationsHonghao Li
Tianjin University
7 shared publicationsZhenyu Liu
Key Laboratory of Systems Bioengineering (Ministry of Education) School of Chemical Engineering and Technology Tianjin University Tianjin China
7 shared publicationsHe Ma
Frontiers Science Center for Synthetic Biology (Ministry of Education), School of Synthetic Biology and Biomanufacturing
6 shared publicationsQingjie Xiao
National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), Chinese Academy of Sciences
6 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by American Chemical Society (ACS) in Chem & Bio Engineering
Harnessing CYP71 Enzymes for Terpenoid Indole Alkaloid Production: A Synthetic Biology Perspective from Discovery to Application
Terpenoid indole alkaloids (TIAs) are a class of structurally diverse natural products with important pharmacological activities. Recently, substantial progress has been made in elucidating TIA biosynthetic pathways, and these studies have revealed the central roles of CYP71 clan enzymes (CYP71s) in both the formation and the modification of the TIA scaffold. In this review, we trace the stepwise elucidation of representative TIA biosynthetic pathways and summarize the functions and catalytic principles of the CYP71s, with emphasis on the reaction types and mechanistic features that underlie their functional versatility. Nevertheless, reconstructing these extended multienzyme pathways in heterologous cell factories remains challenging, in large part because plant cytochrome P450 enzymes (P450s) frequently become rate-limiting owing to inefficient electron transfer and limited cofactor availability. We therefore review metabolic engineering strategies established for P450 systems and assess their applicability to the optimization of CYP71s and to TIA production. We further discuss artificial intelligence (AI)-assisted approaches for CYP71 discovery, functional engineering, and de novo design. Together, these strategies open new avenues for identifying high-performance CYP71s and for advancing TIA biomanufacturing.
- 6 October 2026
- Published by American Chemical Society (ACS) in Chem & Bio Engineering
Open AccessHarnessing CYP71 Enzymes for Terpenoid Indole Alkaloid Production: A Synthetic Biology Perspective from Discovery to Application
Terpenoid indole alkaloids (TIAs) are a class of structurally diverse natural products with important pharmacological activities. Recently, substantial progress has been made in elucidating TIA biosynthetic pathways, and these studies have revealed the central roles of CYP71 clan enzymes (CYP71s) in both the formation and the modification of the TIA scaffold. In this review, we trace the stepwise elucidation of representative TIA biosynthetic pathways and summarize the functions and catalytic principles of the CYP71s, with emphasis on the reaction types and mechanistic features that underlie their functional versatility. Nevertheless, reconstructing these extended multienzyme pathways in heterologous cell factories remains challenging, in large part because plant cytochrome P450 enzymes (P450s) frequently become rate-limiting owing to inefficient electron transfer and limited cofactor availability. We therefore review metabolic engineering strategies established for P450 systems and assess their applicability to the optimization of CYP71s and to TIA production. We further discuss artificial intelligence (AI)-assisted approaches for CYP71 discovery, functional engineering, and de novo design. Together, these strategies open new avenues for identifying high-performance CYP71s and for advancing TIA biomanufacturing.
- 27 May 2026
- Published by Elsevier in Metabolic Engineering
- Vol. 96, 420-433
Deep learning unlocks sequence-divergent synthetic promoters to empower Streptomyces natural product engineering
- 27 May 2026
- Published by Elsevier in Metabolic Engineering
- Vol. 96, 420-433
Deep learning unlocks sequence-divergent synthetic promoters to empower Streptomyces natural product engineering
- Open Access
- 8 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
ZAT-DNA enables DNA data storage with molecular-layer non-replicability
Deoxyribonucleic acid provides unmatched information density and longevity for data storage, yet its easy amplification by polymerase chain reaction enables unauthorized replication at negligible cost. We introduce ZAT-DNA, which encodes information in patterns of canonical adenine and noncanonical 2-aminoadenine. As DNA polymerases cannot distinguish adenine from 2-aminoadenine, polymerase-based amplification erases these patterns, enforcing molecular-layer non-replicability intrinsic to the base-pairing ambiguity. We validate ZAT-DNA for secure key storage, demonstrating error-free encoding, storage, and high-fidelity nanopore retrieval of 32-bit and 64-bit cryptographic keys. ZAT-DNA blocks polymerase-based copying and protects non-fungible tokens by preventing functional duplication. For larger datasets, we present a hybrid “Babel-DNA” architecture: multiple encrypted images are co-encoded in a single regular DNA pool, with each selectively decryptable only via its cognate, non-replicable ZAT-DNA key. This provides a practical framework for molecular access control, secure DNA-encoded databases, and scarce molecular tokens.
- 8 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessZAT-DNA enables DNA data storage with molecular-layer non-replicability
Deoxyribonucleic acid provides unmatched information density and longevity for data storage, yet its easy amplification by polymerase chain reaction enables unauthorized replication at negligible cost. We introduce ZAT-DNA, which encodes information in patterns of canonical adenine and noncanonical 2-aminoadenine. As DNA polymerases cannot distinguish adenine from 2-aminoadenine, polymerase-based amplification erases these patterns, enforcing molecular-layer non-replicability intrinsic to the base-pairing ambiguity. We validate ZAT-DNA for secure key storage, demonstrating error-free encoding, storage, and high-fidelity nanopore retrieval of 32-bit and 64-bit cryptographic keys. ZAT-DNA blocks polymerase-based copying and protects non-fungible tokens by preventing functional duplication. For larger datasets, we present a hybrid “Babel-DNA” architecture: multiple encrypted images are co-encoded in a single regular DNA pool, with each selectively decryptable only via its cognate, non-replicable ZAT-DNA key. This provides a practical framework for molecular access control, secure DNA-encoded databases, and scarce molecular tokens.
- Open Access
- 31 March 2026
- Published by Wiley in Advanced Science
- Vol. 13 (34) , e75061
Enzymatic Basis for the Oxidative Branch of Aromatic Amino Acid Fermentation Leading to p ‐cresol Formation
The phenolic metabolite p ‐cresol is a byproduct of tyrosine fermentation by certain strictly anaerobic bacteria, including the human gut pathogen Clostridium difficile , with toxic effects on the host and intestinal microbiota. The only enzyme in this biochemical pathway characterized to date is the glycyl radical enzyme p ‐hydroxyphenylacetate (HPA) decarboxylase (HPAD), which catalyzes the terminal step. Here we report the identification and characterization of enzymes for anaerobic degradation of tyrosine to HPA in the model p‐ cresol‐producing bacterium Clostridium scatologenes . In this pathway, tyrosine is first converted to p‐ hydroxyphenylpyruvate (HPP), followed by net oxidation to HPA by a trio of enzymes HPP: ferredoxin oxidoreductase (HpdDEFG), phosphate HPA‐transferase (HpdJ) and HPA kinase (HpdK). Each step is thermodynamically reversible, and the pathway is coupled to net generation of ATP and reduced ferredoxin. A bioinformatics search reveals that gene clusters containing a similar trio of enzymes are widespread in anaerobic Firmicutes bacteria, suggesting analogous pathways for the degradation of other amino acids. These findings clarify the oxidative pathways by which anaerobic gut bacteria convert aromatic amino acids into a major class of aromatic metabolites including HPA and p ‐cresol, deepening our understanding of microbiota–host metabolic interactions.
- 31 March 2026
- Published by Wiley in Advanced Science
- Vol. 13 (34) , e75061
Open AccessEnzymatic Basis for the Oxidative Branch of Aromatic Amino Acid Fermentation Leading to p ‐cresol Formation
The phenolic metabolite p ‐cresol is a byproduct of tyrosine fermentation by certain strictly anaerobic bacteria, including the human gut pathogen Clostridium difficile , with toxic effects on the host and intestinal microbiota. The only enzyme in this biochemical pathway characterized to date is the glycyl radical enzyme p ‐hydroxyphenylacetate (HPA) decarboxylase (HPAD), which catalyzes the terminal step. Here we report the identification and characterization of enzymes for anaerobic degradation of tyrosine to HPA in the model p‐ cresol‐producing bacterium Clostridium scatologenes . In this pathway, tyrosine is first converted to p‐ hydroxyphenylpyruvate (HPP), followed by net oxidation to HPA by a trio of enzymes HPP: ferredoxin oxidoreductase (HpdDEFG), phosphate HPA‐transferase (HpdJ) and HPA kinase (HpdK). Each step is thermodynamically reversible, and the pathway is coupled to net generation of ATP and reduced ferredoxin. A bioinformatics search reveals that gene clusters containing a similar trio of enzymes are widespread in anaerobic Firmicutes bacteria, suggesting analogous pathways for the degradation of other amino acids. These findings clarify the oxidative pathways by which anaerobic gut bacteria convert aromatic amino acids into a major class of aromatic metabolites including HPA and p ‐cresol, deepening our understanding of microbiota–host metabolic interactions.
- 12 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1389-1399
Reprogramming Carbon Partition for Salidroside Overproduction in Saccharomyces cerevisiae
Salidroside, a valuable plant-derived glycoside, holds great promise for nutraceutical and pharmaceutical applications. Although microbial biosynthesis has been established, further enhancement of its production faces a universal bottleneck in glycoside synthesis: the competition for the glycosyl donor UDP-glucose (UDPG) between essential cell wall construction and target product formation. To overcome this fundamental conflict, we constructed a high-yielding microbial cell factory through a systematic engineering strategy. We first rewired central metabolism via a thiamine diphosphate (ThDP) regeneration strategy to secure a high-level production of the precursor tyrosol. Subsequently, the introduction of a glycosyltransferase RrU8GT33 from Rhodiola rosea enabled the conversion of tyrosol to salidroside. To address the key limitation, we enhanced UDP-glucose availability by overexpressing UDP-glucose pyrophosphorylase (UGP1) and phosphoglucose mutase (PGM1), and most critically implemented cell wall engineering to dynamically redirect carbon flux from biomass synthesis toward salidroside production by regulating β-1,3-glucan synthase (FKS1) expression. This approach effectively decouples growth pressure from the synthesis demand. Subsequent engineering steps alleviated physiological constraints, yielding a robust production host. In a bioreactor fermentation, the final strain achieved a record-breaking salidroside titer of 40.46 g/L, with a productivity of 0.24 g/(L h) and a yield of 0.27 g/g glucose. This work demonstrates the efficacy of cofactor and cell wall engineering in optimizing glycoside production and provides a scalable strategy for the microbial manufacturing of high-value natural glycosides.
- 12 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1389-1399
Reprogramming Carbon Partition for Salidroside Overproduction in Saccharomyces cerevisiae
Salidroside, a valuable plant-derived glycoside, holds great promise for nutraceutical and pharmaceutical applications. Although microbial biosynthesis has been established, further enhancement of its production faces a universal bottleneck in glycoside synthesis: the competition for the glycosyl donor UDP-glucose (UDPG) between essential cell wall construction and target product formation. To overcome this fundamental conflict, we constructed a high-yielding microbial cell factory through a systematic engineering strategy. We first rewired central metabolism via a thiamine diphosphate (ThDP) regeneration strategy to secure a high-level production of the precursor tyrosol. Subsequently, the introduction of a glycosyltransferase RrU8GT33 from Rhodiola rosea enabled the conversion of tyrosol to salidroside. To address the key limitation, we enhanced UDP-glucose availability by overexpressing UDP-glucose pyrophosphorylase (UGP1) and phosphoglucose mutase (PGM1), and most critically implemented cell wall engineering to dynamically redirect carbon flux from biomass synthesis toward salidroside production by regulating β-1,3-glucan synthase (FKS1) expression. This approach effectively decouples growth pressure from the synthesis demand. Subsequent engineering steps alleviated physiological constraints, yielding a robust production host. In a bioreactor fermentation, the final strain achieved a record-breaking salidroside titer of 40.46 g/L, with a productivity of 0.24 g/(L h) and a yield of 0.27 g/g glucose. This work demonstrates the efficacy of cofactor and cell wall engineering in optimizing glycoside production and provides a scalable strategy for the microbial manufacturing of high-value natural glycosides.
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 16 (7) , 2481-2488
Nanocapsule engineering endows aldolase with robust organic-solvent tolerance and enhanced catalytic efficiency
This study constructed nanoencapsulated aldolase 7080 via a two-step in situ chemical modification, greatly boosting its catalytic efficiency for C–C bond formation from fluorobenzaldehyde substrates in high DMSO concentrations.
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 16 (7) , 2481-2488
Nanocapsule engineering endows aldolase with robust organic-solvent tolerance and enhanced catalytic efficiency
This study constructed nanoencapsulated aldolase 7080 via a two-step in situ chemical modification, greatly boosting its catalytic efficiency for C–C bond formation from fluorobenzaldehyde substrates in high DMSO concentrations.
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (2) , 387-399
Biosynthesis of Indigoidine in Microorganisms: Strategies and Applications
Indigoidine, a microbial-derived pyridone pigment, has emerged as a promising sustainable alternative to synthetic blue dyes in textile industry. Its biosynthesis is mediated by nonribosomal peptide synthetases (NRPSs), offering a favorable alternative to conventional chemical synthesis for pigment production. Recent advances in synthetic biology have facilitated the scalable engineering of microbial chassis strains, enabling industrial level pigment production. However, challenges persist in pathway optimization, titer improvement, and application diversity. In this review, we systematically examine microbial host systems, metabolic and enzyme engineering approaches, and synthetic biology techniques to enhance indigoidine production. This review offers a roadmap for advancing next-generation microbial cell factories for pigment manufacturing.
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (2) , 387-399
Biosynthesis of Indigoidine in Microorganisms: Strategies and Applications
Indigoidine, a microbial-derived pyridone pigment, has emerged as a promising sustainable alternative to synthetic blue dyes in textile industry. Its biosynthesis is mediated by nonribosomal peptide synthetases (NRPSs), offering a favorable alternative to conventional chemical synthesis for pigment production. Recent advances in synthetic biology have facilitated the scalable engineering of microbial chassis strains, enabling industrial level pigment production. However, challenges persist in pathway optimization, titer improvement, and application diversity. In this review, we systematically examine microbial host systems, metabolic and enzyme engineering approaches, and synthetic biology techniques to enhance indigoidine production. This review offers a roadmap for advancing next-generation microbial cell factories for pigment manufacturing.
- 22 January 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Directed Evolution Boosts UGT85A1 Glycosylation for Enhanced Phenylethanoid Glucoside Production
Glycosides are diverse plant metabolites with important biological functions. Salidroside and its derivatives, natural phenylethanoid glycosides, have considerable potential in food and pharmaceutical applications, but their low natural abundance limits large-scale production. Microbial biosynthesis offers a sustainable alternative, where glycosyltransferase efficiency is critical. Here, we engineered UGT85A1 via iterative saturation mutagenesis (ISM), yielding the high-activity mutant DHG (G114D/F217H/C128G) with a 23.6-fold increase in catalytic efficiency. Molecular dynamics analyses indicated that DHG's enhanced activity stems from stabilized substrate binding and optimized catalytic geometry. In tyrosol- and hydroxytyrosol-overproducing yeast strains, DHG enabled salidroside and hydroxysalidroside production of 2.70 g/L (4.6×) and 1.63 g/L (19.4×), respectively─the highest titers reported in S. cerevisiae in shake-flask cultures (50 mL). This work provides a robust platform and general strategy for engineering plant UGTs to expand microbial production of high-value glycosides.
- 22 January 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Directed Evolution Boosts UGT85A1 Glycosylation for Enhanced Phenylethanoid Glucoside Production
Glycosides are diverse plant metabolites with important biological functions. Salidroside and its derivatives, natural phenylethanoid glycosides, have considerable potential in food and pharmaceutical applications, but their low natural abundance limits large-scale production. Microbial biosynthesis offers a sustainable alternative, where glycosyltransferase efficiency is critical. Here, we engineered UGT85A1 via iterative saturation mutagenesis (ISM), yielding the high-activity mutant DHG (G114D/F217H/C128G) with a 23.6-fold increase in catalytic efficiency. Molecular dynamics analyses indicated that DHG's enhanced activity stems from stabilized substrate binding and optimized catalytic geometry. In tyrosol- and hydroxytyrosol-overproducing yeast strains, DHG enabled salidroside and hydroxysalidroside production of 2.70 g/L (4.6×) and 1.63 g/L (19.4×), respectively─the highest titers reported in S. cerevisiae in shake-flask cultures (50 mL). This work provides a robust platform and general strategy for engineering plant UGTs to expand microbial production of high-value glycosides.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
Rare functional groups and unique scaffolds in Streptomyces natural products
This review highlights Streptomyces natural products with rare functional groups, unique scaffolds, and atypical modifications, examining the enzymatic mechanisms to link biosynthetic diversity with synthetic biology applications.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
Rare functional groups and unique scaffolds in Streptomyces natural products
This review highlights Streptomyces natural products with rare functional groups, unique scaffolds, and atypical modifications, examining the enzymatic mechanisms to link biosynthetic diversity with synthetic biology applications.
- Open Access
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Structural-guided identification of two modulators of β−1,3-glucan synthase FKS1
FKS1 is a β−1,3-glucan synthase critical for fungal cell wall formation and a target for antifungal drugs such as echinocandin and ibrexafungerp. However, the mechanisms regulating FKS1 activity remain largely unknown. Here, we reveal that transfer RNA (tRNA) acts as an endogenous inhibitor, whereas GSR1 functions as a stabilizer of FKS1. The cryo-EM structure of FKS1 adopts a tRNA-mediated homodimer configuration, representing a quiescent state of β−1,3-glucan synthase. Unexpectedly, the copurified endogenous tRNA is identified as a potent inhibitor that suppresses FKS1 activity. Moreover, high-resolution cryo-EM density analysis enable the identification of GSR1 as an additional binding partner of FKS1. Mutagenesis experiments confirm the interaction between FKS1 and GSR1. Evolutionarily conserved GSR1 is found to increase the stability of FKS1 in β−1,3-glucan biosynthesis. Collectively, our findings identify both tRNA and GSR1 as intrinsic modulators of β−1,3-glucan biosynthesis, thereby providing opportunities for the further development of FKS1-targeted antifungal drugs.
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessStructural-guided identification of two modulators of β−1,3-glucan synthase FKS1
FKS1 is a β−1,3-glucan synthase critical for fungal cell wall formation and a target for antifungal drugs such as echinocandin and ibrexafungerp. However, the mechanisms regulating FKS1 activity remain largely unknown. Here, we reveal that transfer RNA (tRNA) acts as an endogenous inhibitor, whereas GSR1 functions as a stabilizer of FKS1. The cryo-EM structure of FKS1 adopts a tRNA-mediated homodimer configuration, representing a quiescent state of β−1,3-glucan synthase. Unexpectedly, the copurified endogenous tRNA is identified as a potent inhibitor that suppresses FKS1 activity. Moreover, high-resolution cryo-EM density analysis enable the identification of GSR1 as an additional binding partner of FKS1. Mutagenesis experiments confirm the interaction between FKS1 and GSR1. Evolutionarily conserved GSR1 is found to increase the stability of FKS1 in β−1,3-glucan biosynthesis. Collectively, our findings identify both tRNA and GSR1 as intrinsic modulators of β−1,3-glucan biosynthesis, thereby providing opportunities for the further development of FKS1-targeted antifungal drugs.